Fig. 2From: Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancersSerum CA125 and ascites IL-6 levels can discriminate between patients with serous EOC or benign gynecological conditions. The markers with cutoff (pg/ml for IL-6 and kUI/L for CA125) are depicted together with the percentage of the patients with EOC or benign conditions that were predicted by the combination of markersBack to article page